FDA Authorizes Shelf-Life Extension for REGEN-COV - HHS.gov
https://stg-aspr.hhs.gov/COVID-19/Therapeutics/updates/Pages/important-update-27June2022.aspx
Web ResultOn June 27, 2022, FDA authorized an extension to the shelf-life from 24 months to 30 months for specific lots of the refrigerated Regeneron monoclonal antibodies, casirivimab and imdevimab, administered together or REGEN-COV (see Table 1, Table 2, and Table 3 below).
DA: 15 PA: 80 MOZ Rank: 1